Related Experiment Video
Updated: May 22, 2026
Neonatal Murine Cochlear Explant Technique as an In Vitro Screening Tool in Hearing Research
Published on: June 8, 2017
Implementation and results of bedside hearing screening with automated auditory brainstem response in the neonatal
Koenraad Smets1, Nele Verrue, Ingeborg Dhooge
1Neonatal Intensive Care Unit, Ghent University Hospital, Belgium. koenraad.smets@ugent.be
Aim:
To evaluate implementation and results of neonatal hearing screening with automated auditory brainstem response (AABR) by bedside nurses in a single-centre neonatal intensive care unit (NICU).
Methods:
Retrospective review of charts of 2074 newborns admitted over a 4-year period.
Results:
One thousand eight hundred and 24 newborns (88%) were screened. A 'pass' result was obtained in 1761 patients (96.5%). From 63 infants with 'refer', 40 were tested with auditory brainstem response: in 28 hearing loss was confirmed. Three hundred and nine neonates were screened before postmenstrual age (PMA) of 34 weeks: 78% successfully passed the first test. Sixty-seven infants with 'refer' at the first test before PMA of 34 weeks were re-evaluated: 48 had normal hearing tests, 24 of whom still younger than 34 weeks. For 12 of 19 infants with 'refer' before 34 weeks, follow-up was available: in 7 hearing loss was confirmed.
Conclusion:
Neonatal hearing screening with AABR can be easily performed by the bedside nurse in the NICU even in premature babies before 34 weeks PMA. A 'pass' result can be obtained in almost 80% of them; a 'refer' result at that age, however, must be interpreted cautiously, as false 'refer' occurred in 5/12 of these infants.
